Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit


Female Sex Health Dialogue Continues

Dec 15, 2014

Female Sex Health Dialogue ContinuesThe drug flibanserin, sometimes called “pink Viagra,” has been in the news quite a bit these days, but not without controversy.

Promoted by Sprout Pharmaceuticals, flibanserin is designed to treat women with hypoactive sexual desire disorder (HSDD). This condition is marked by a persistent lack of sexual interest, to the point that causes women distress.


Flibanserin continues to spark discussion, even controversy...
Click here to tweet.


The U.S. Food and Drug Administration (FDA) has not approved flibanserin. In October, however, the agency held a public meeting to discuss female sexual dysfunction and its treatment.


1 2 3 Next » (page 1 of 3)